ONCSQ (OncoSec Medical) Beginning Cash Position: $5.72 Mil (As of Jan. 2023)


What is OncoSec Medical Beginning Cash Position?

OncoSec Medical ONCSQ -99.00% Beginning Cash Position is $5.72 Mil as of Jan. 2023.

OncoSec Medical's Beginning Cash Position for the quarter that ended in Jan. 2023 was $5.72 Mil.

OncoSec Medical's quarterly Beginning Cash Position declined from Jul. 2022 ($19.48 Mil) to Oct. 2022 ($12.30 Mil) and declined from Oct. 2022 ($12.30 Mil) to Jan. 2023 ($5.72 Mil).

OncoSec Medical's annual Beginning Cash Position declined from Jul. 2020 ($25.15 Mil) to Jul. 2021 ($20.36 Mil) but then increased from Jul. 2021 ($20.36 Mil) to Jul. 2022 ($45.95 Mil).

OncoSec Medical Beginning Cash Position Related Terms

OncoSec Medical Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Beginning Cash Position Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.45 3.80 25.15 20.36 45.95

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.46 25.23 19.48 12.30 5.72

OncoSec Medical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $5.72 Mil mean?
OncoSec Medical (ONCSQ) has a Beginning Cash Position of $5.72 Mil as of Jan. 2023. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Beginning Cash Position too high?
OncoSec Medical's current Beginning Cash Position is $5.72 Mil.
How does OncoSec Medical's Beginning Cash Position compare to NOVNQ and USRM?
OncoSec Medical's Beginning Cash Position of $5.72 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Beginning Cash Position is $5.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Beginning Cash Position of $5.72 Mil. The current Beginning Cash Position is $5.72 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Beginning Cash Position is $5.72 Mil as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.